N,N-dimethyldoxorubicin

RN given refers to parent cpd(8S-cis)-isomer

Also Known As:

N,N-dimethyladriamycin; N,N-dimethyldoxorubicin hydrochloride, (8S-cis)-isomer; N,N-dimethyldoxorubicin monohydrochloride; 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Proliferative Vitreoretinopathy 04/01/1993 - "N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina."
2.	Acute Erythroblastic Leukemia (Erythroleukemia) 02/01/1991 - "The effect of adriamycin, daunomycin, N,N-dimethyladriamycin, N,N-dimethyldaunomycin, pyrromycin, marcellomycin, and aclacinomycin A on erythroid differentiation and glycoprotein synthesis in Friend erythroleukemia cells, clone F4-6 was investigated. "

Related Drugs and Biologics

1.	Aclarubicin
2.	Glycoproteins (Glycoprotein)
3.	Doxorubicin (Adriamycin)
4.	Daunorubicin (Cerubidine)
5.	N,N-dimethyldaunorubicin
6.	pyrromycin
7.	marcellomycin